Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 04 Nov 2025 07:30 CET |
MAAT PHARMA | MaaT Pharma fait le point sur ses activités de financement et publie ses résultats financiers pour le troisième trimestre 2025 | 20103010 Biotechnology | Other subject |
| 04 Nov 2025 07:29 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:03 CET |
Aker ASA | Key information relating to cash dividend | 30202000 Diversified Financial Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 07:02 CET |
KINEPOLIS GROUP | Kinepolis sluit overeenkomst tot overname van de activiteiten van de Amerikaanse bioscoopketen Emagine Entertainment | 40301010 Entertainment | Mergers, Acquiqitions, Transferts |
| 04 Nov 2025 07:02 CET |
KINEPOLIS GROUP | Kinepolis signe un accord pour l'acquisition des activités de la chaîne de cinémas américaine Emagine Entertainment | 40301010 Entertainment | Mergers, Acquiqitions, Transferts |
| 04 Nov 2025 07:02 CET |
KINEPOLIS GROUP | Kinepolis signs agreement to acquire the operations of US movie theatre chain Emagine Entertainment | 40301010 Entertainment | Mergers, Acquiqitions, Transferts |
| 04 Nov 2025 07:01 CET |
BIOMERIEUX | bioMérieux – Information financière du 3ème trimestre 2025 | 20102010 Medical Equipment | Other subject |
| 04 Nov 2025 07:01 CET |
BIOMERIEUX | bioMérieux – Third-Quarter 2025 Business Review | 20102010 Medical Equipment | Other subject |
| 04 Nov 2025 07:00 CET |
EDENRED | Edenred unveils Amplify25-28, its new strategic plan | 50205015 Transaction Processing Services | Legal |
| 04 Nov 2025 07:00 CET |
EDENRED | Edenred dévoile son nouveau plan stratégique Amplify25-28 | 50205015 Transaction Processing Services | Legal |
| 04 Nov 2025 07:00 CET |
SMARTCRAFT ASA | SmartCraft ASA (SMCRT) - Q3 2025: Strong profitability and strategic progress | 10101015 Software | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
NRC Group ASA | NRC Group ASA today published its financial results for the third quarter of 2025 | 50101010 Construction | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
MULTICONSULT | Multiconsult third quarter 2025 - stable performance in a competitive market | 50101015 Engineering and Contracting Services | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
CLOUDBERRY CLEAN ENERGY ASA | Cloudberry Clean Energy ASA | Third quarter 2025 report | 65101010 Alternative Electricity | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
Aker ASA | Aker ASA reports third quarter results 2025 | 30202000 Diversified Financial Services | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Nov 2025 07:00 CET |
KONINKLIJKE PHILIPS N.V. | Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion | 20102010 Medical Equipment | - |
| 04 Nov 2025 07:00 CET |
Bustadkreditt Sogn og Fjordane | Bustadkreditt Sogn og Fjordane - interim report Q3 2025 | - | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 07:00 CET |
NOKIA | Nokia aikoo hakea osakkeidensa listalta poistamista Pariisin pörssistä | 15101010 Telecommunications Equipment | - |
| 04 Nov 2025 07:00 CET |
VALNEVA SE | Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate | 20103015 Pharmaceuticals | Products and services |
| 04 Nov 2025 07:00 CET |
ZELLUNA | Zelluna ASA - Ex. date | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 07:00 CET |
DSM FIRMENICH AG | Weekly progress on share repurchase program to cover share plans and reduce capital | 45102020 Food Products | Change in Capital |
| 04 Nov 2025 07:00 CET |
WERELDHAVE Gewone aandelen | Wereldhave Trading update Q3 2025 | 35102045 Retail REITs | Commercial results |
| 04 Nov 2025 07:00 CET |
VALNEVA SE | Valneva annonce des résultats positifs de Phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika | 20103015 Pharmaceuticals | Products and services |
| 04 Nov 2025 07:00 CET |
Bustadkreditt Sogn og Fjordane | Bustadkreditt Sogn og Fjordane - 3. kvartal 2025 | - | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 04 Nov 2025 07:00 CET |
ARCADIS | Arcadis reports transactions under its current share buyback program | 50101015 Engineering and Contracting Services | Other financial transaction |
| 04 Nov 2025 07:00 CET |
Loch Duart plc 24/28 FRN FLOOR C | Loch Duart PLC – First day of trading of bonds and notice of home member state | - | Home Member State |
| 04 Nov 2025 07:00 CET |
COOL COMPANY LTD. | Cool Company Ltd Announces Record Date for Special Meeting for Proposed Merger with Newly Formed, Wholly Owned Subsidiary of EPS Ventures Ltd | 50206030 Marine Transportation | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 07:00 CET |
NOKIA | Nokia announces intention to seek a delisting from Paris Stock Exchange | 15101010 Telecommunications Equipment | - |
| 04 Nov 2025 06:00 CET |
OKEA ASA | OKEA ASA - Third quarter 2025 financial results | 60101010 Oil: Crude Producers | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 06:00 CET |
BAKKAFROST | Record biology in the Faroes drives lower costs - a strong foundation for sustainable growth | 45102010 Farming, Fishing, Ranching and Plantations | Half yearly financial reports and audit reports/limited reviews |
| 04 Nov 2025 00:58 CET |
ZELLUNA | Zelluna ASA - Key information relating to subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:35 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 23:52 CET |
ZELLUNA | Zelluna ASA - Successful private placement and retail offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 23:15 CET |
HIPAY GROUP | Q3 2025 Consolidated Revenue | 50205015 Transaction Processing Services | Commercial results |
| 03 Nov 2025 23:15 CET |
HIPAY GROUP | Chiffre d'affaires du troisième trimestre 2025 | 50205015 Transaction Processing Services | Commercial results |
| 03 Nov 2025 22:55 CET |
HIPAY GROUP | Calendrier financier 2026 | 50205015 Transaction Processing Services | Corporate life |
| 03 Nov 2025 22:50 CET |
HIPAY GROUP | 2026 Financial Calendar | 50205015 Transaction Processing Services | Corporate life |
| 03 Nov 2025 22:30 CET |
DBV TECHNOLOGIES | DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial | 20103010 Biotechnology | Other subject |
| 03 Nov 2025 22:30 CET |
DBV TECHNOLOGIES | DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer | 20103010 Biotechnology | Other subject |
| 03 Nov 2025 22:30 CET |
BANIJAY GROUP N.V. | Banijay Group: weekly share transactions | 40301010 Entertainment | Other subject |
| 03 Nov 2025 22:25 CET |
DBV TECHNOLOGIES | Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2025 | 20103010 Biotechnology | Other subject |
| 03 Nov 2025 22:25 CET |
DBV TECHNOLOGIES | Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 | 20103010 Biotechnology | Other subject |
| 03 Nov 2025 22:20 CET |
VRANKEN-POMMERY | VRANKEN-POMMERY MONOPOLE - COMMUNIQUE DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE EXTRAORDINAIRE | 45101015 Distillers and Vintners | General meeting / Board Meeting |
| 03 Nov 2025 22:20 CET |
VRANKEN-POMMERY | VRANKEN-POMMERY MONOPOLE : Availability Preparatoy Documents of Extraordinary General Meeting of 24th November 2025 | 45101015 Distillers and Vintners | General meeting / Board Meeting |
| 03 Nov 2025 22:15 CET |
NANOBIOTIX | NANOBIOTIX to Participate in Investor Conferences the Week of November 10th | 20103010 Biotechnology | Meetings / events |
| 03 Nov 2025 22:15 CET |
NANOBIOTIX | NANOBIOTIX participera à des conférences investisseurs la semaine du 10 novembre | 20103010 Biotechnology | Meetings / events |
| 03 Nov 2025 22:05 CET |
ABIVAX | Abivax annonce les résultats rapportés par les patients issus des essais d'induction ABTECT de phase 3 évaluant Obefazimod, ... | 20103010 Biotechnology | Other subject |
| 03 Nov 2025 22:05 CET |
NYXOAH SA | Nyxoah Participera à la Conférence Stifel Healthcare 2025 | 20102010 Medical Equipment | Other subject |
| 03 Nov 2025 22:05 CET |
NYXOAH SA | Nyxoah to Participate in the Stifel 2025 Healthcare Conference | 20102010 Medical Equipment | Other subject |